Germany-based BioNTech got into the space before the gold rush that was unleashed in September by the news that Akeso and ...

Michael Okunewitch, an analyst from Maxim Group, maintained the Buy rating on Citius Pharmaceuticals (CTXR – Research Report). The ...

Vernon Bernardino has given his Buy rating due to a combination of factors, including promising preliminary results from Citius Pharmaceuticals’ ongoing clinical trial of Lymphir in combination with ...

Welcome to the Merck & Company Q3 sales and earnings conference call. [Operator instructions] This call is being recorded.

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for trea ...

Baking soda (sodium bicarbonate) does not prevent or cure cancer, but some research suggests it may help boost the effectiveness of conventional cancer treatments, such as chemotherapy. Baking soda is ...

Either preoperative chemoradiotherapy or preoperative/perioperative chemotherapy can be recommended to patients with esophageal or gastroesophageal junction cancer ...

The Phase 3 trial (STAR-121) is appraising the combo against Keytruda + chemo with a third arm of zim + chemo, randomized 4:4:1. The primary endpoints are OS and PFS with key secondary endpoints ...

In patients with negative PD-L1 expression (CPS <1) in Cohort B, efti in combination with KEYTRUDA&circledR; achieved a 35.5% objective response rate (ORR). This is among the highest recorded for a ...

This approach could avoid the side effects that often occur when chemotherapy is given intravenously, and the synergistic effect of the two therapies may extend the patient's lifespan longer than ...

3A or 3B non-small cell lung cancer whose disease did not completely respond to neoadjuvant Keytruda plus platinum-based chemotherapy. Global recruitment has also started for this trial, with the ...